A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,206 shares of VXRT stock, worth $5,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,206
Previous 10,206 -0.0%
Holding current value
$5,919
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$0.57 - $0.85 $455 - $680
-800 Reduced 7.27%
10,206 $5,000
Q3 2023

Nov 13, 2023

BUY
$0.69 - $0.85 $7,594 - $9,355
11,006 New
11,006 $8,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.